SU1042614A3 - Способ получени 2-бензил-3-(3-диметиламинопропилтио)-2 @ -индазола - Google Patents
Способ получени 2-бензил-3-(3-диметиламинопропилтио)-2 @ -индазола Download PDFInfo
- Publication number
- SU1042614A3 SU1042614A3 SU802883703A SU2883703A SU1042614A3 SU 1042614 A3 SU1042614 A3 SU 1042614A3 SU 802883703 A SU802883703 A SU 802883703A SU 2883703 A SU2883703 A SU 2883703A SU 1042614 A3 SU1042614 A3 SU 1042614A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- mol
- benzyl
- mixture
- propylthio
- indasole
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 238000000034 method Methods 0.000 claims abstract description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000008096 xylene Substances 0.000 claims description 6
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 13
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 7
- 230000001575 pathological effect Effects 0.000 abstract description 2
- VPMZGRVNLHDREW-UHFFFAOYSA-N 3-(2-benzylindazol-3-yl)sulfanyl-n,n-dimethylpropan-1-amine Chemical class N1=C2C=CC=CC2=C(SCCCN(C)C)N1CC1=CC=CC=C1 VPMZGRVNLHDREW-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003457 sulfones Chemical class 0.000 abstract 1
- 150000003462 sulfoxides Chemical class 0.000 abstract 1
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 16
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229960000333 benzydamine Drugs 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 230000003444 anaesthetic effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003589 local anesthetic agent Substances 0.000 description 6
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 229960001138 acetylsalicylic acid Drugs 0.000 description 5
- 229960000905 indomethacin Drugs 0.000 description 5
- 229960002895 phenylbutazone Drugs 0.000 description 5
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000010992 reflux Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 2
- -1 3-chloropropyl- Chemical group 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000001562 ulcerogenic effect Effects 0.000 description 2
- BKHQZVDOSQVERW-UHFFFAOYSA-N 1,5-dimethyl-2-phenylpyrazole-3-thione Chemical compound CN1C(C)=CC(=S)N1C1=CC=CC=C1 BKHQZVDOSQVERW-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- PYSGFFTXMUWEOT-UHFFFAOYSA-N 3-(dimethylamino)propan-1-ol Chemical compound CN(C)CCCO PYSGFFTXMUWEOT-UHFFFAOYSA-N 0.000 description 1
- VTWZICMJJJQLKT-UHFFFAOYSA-N 3-(dimethylamino)propyl 4-methylbenzenesulfonate Chemical compound CN(C)CCCOS(=O)(=O)C1=CC=C(C)C=C1 VTWZICMJJJQLKT-UHFFFAOYSA-N 0.000 description 1
- BQSZFOGVHFAQGY-UHFFFAOYSA-N 3-indazol-2-ylsulfanyl-N,N-dimethylpropan-1-amine Chemical compound CN(C)CCCSN1N=C2C=CC=CC2=C1 BQSZFOGVHFAQGY-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002973 irritant agent Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229950002475 mesilate Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20305/79A IT1110282B (it) | 1979-02-19 | 1979-02-19 | Tio-indazoli basici |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1042614A3 true SU1042614A3 (ru) | 1983-09-15 |
Family
ID=11165582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU802883703A SU1042614A3 (ru) | 1979-02-19 | 1980-02-18 | Способ получени 2-бензил-3-(3-диметиламинопропилтио)-2 @ -индазола |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4264618A (enExample) |
| JP (1) | JPS605590B2 (enExample) |
| AT (1) | ATA91780A (enExample) |
| AU (1) | AU518489B2 (enExample) |
| CA (1) | CA1131234A (enExample) |
| DD (2) | DD157255A5 (enExample) |
| DE (1) | DE3000690A1 (enExample) |
| DK (1) | DK69880A (enExample) |
| ES (1) | ES488719A0 (enExample) |
| FI (1) | FI800295A7 (enExample) |
| FR (3) | FR2453156A1 (enExample) |
| GB (3) | GB2043069B (enExample) |
| HU (1) | HU184721B (enExample) |
| IE (1) | IE49399B1 (enExample) |
| IL (1) | IL59271A0 (enExample) |
| IT (1) | IT1110282B (enExample) |
| NL (1) | NL8000610A (enExample) |
| PL (1) | PL130717B1 (enExample) |
| PT (1) | PT70835A (enExample) |
| SE (1) | SE8001279L (enExample) |
| SU (1) | SU1042614A3 (enExample) |
| YU (3) | YU39880A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6190642B1 (en) | 1988-02-19 | 2001-02-20 | Dentsply Research & Development Corp. | Irrigating and lavage compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3145215A (en) * | 1961-12-19 | 1964-08-18 | Sterling Drug Inc | Indazole derivatives |
| GB1054833A (enExample) * | 1963-08-09 | |||
| US3428634A (en) * | 1965-03-13 | 1969-02-18 | Acraf | 3-tertiary amino alkoxy-1-hydrocarbon indazoles |
| US3637738A (en) * | 1969-02-12 | 1972-01-25 | Ciba Geigy Corp | Cycloalkano(c)pyrazole ethers |
| US4182769A (en) * | 1977-02-09 | 1980-01-08 | E. I. Du Pont De Nemours And Company | Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones |
-
1979
- 1979-02-19 IT IT20305/79A patent/IT1110282B/it active
- 1979-12-11 US US06/102,509 patent/US4264618A/en not_active Expired - Lifetime
-
1980
- 1980-01-10 DE DE19803000690 patent/DE3000690A1/de not_active Withdrawn
- 1980-01-30 IL IL59271A patent/IL59271A0/xx unknown
- 1980-01-31 NL NL8000610A patent/NL8000610A/nl not_active Application Discontinuation
- 1980-01-31 FI FI800295A patent/FI800295A7/fi not_active Application Discontinuation
- 1980-02-06 FR FR8002622A patent/FR2453156A1/fr active Granted
- 1980-02-07 AU AU55318/80A patent/AU518489B2/en not_active Ceased
- 1980-02-14 YU YU00398/80A patent/YU39880A/xx unknown
- 1980-02-14 CA CA345,682A patent/CA1131234A/en not_active Expired
- 1980-02-14 GB GB8005082A patent/GB2043069B/en not_active Expired
- 1980-02-15 PT PT70835A patent/PT70835A/pt unknown
- 1980-02-18 DK DK69880A patent/DK69880A/da not_active Application Discontinuation
- 1980-02-18 SE SE8001279A patent/SE8001279L/xx not_active Application Discontinuation
- 1980-02-18 ES ES488719A patent/ES488719A0/es active Granted
- 1980-02-18 IE IE296/80A patent/IE49399B1/en unknown
- 1980-02-18 SU SU802883703A patent/SU1042614A3/ru active
- 1980-02-18 JP JP55018946A patent/JPS605590B2/ja not_active Expired
- 1980-02-18 PL PL1980222090A patent/PL130717B1/pl unknown
- 1980-02-18 HU HU80367A patent/HU184721B/hu unknown
- 1980-02-19 AT AT0091780A patent/ATA91780A/de not_active IP Right Cessation
- 1980-02-19 DD DD80228371A patent/DD157255A5/de unknown
- 1980-02-19 DD DD80219140A patent/DD149806A5/de unknown
- 1980-07-03 FR FR8014867A patent/FR2450823A1/fr active Granted
- 1980-07-03 FR FR8014866A patent/FR2450822A1/fr active Granted
-
1982
- 1982-10-15 GB GB08229492A patent/GB2108957B/en not_active Expired
- 1982-10-15 GB GB08229493A patent/GB2108958B/en not_active Expired
- 1982-11-22 YU YU02606/82A patent/YU260682A/xx unknown
- 1982-11-22 YU YU02605/82A patent/YU260582A/xx unknown
Non-Patent Citations (1)
| Title |
|---|
| 1. Патент US 3318905, кл. 85-47, 05.05.67. 2. Эльдерфилд Р. Гетероциклические соединени М. , Мир, 1961, т. 5, с. 116. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3752826A (en) | Aroyl substituted pyrroles | |
| IE47592B1 (en) | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture | |
| NO118710B (enExample) | ||
| NO162176B (no) | Middel for bekjempelse av plantesykdommer og anvendelse derav. | |
| US4147780A (en) | α-Amino-phosphonous acids for inhibiting bacteria and yeast | |
| NO164214B (no) | Fremgangsmaate for fremstilling av en bruksferdig, dehydratisert belgfroepure. | |
| SU1156593A3 (ru) | Способ получени производных бензамида или их кислотно-аддитивных солей,или оптических изомеров | |
| US4036964A (en) | Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis | |
| EP0349432B1 (fr) | Sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant | |
| NO163814B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-substituerte 4-hydroksymetyl-pyrrolidinon-derivater. | |
| SU1042614A3 (ru) | Способ получени 2-бензил-3-(3-диметиламинопропилтио)-2 @ -индазола | |
| NO137858B (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive indanoner | |
| US3459767A (en) | Aminomethylindoles | |
| US3763218A (en) | Esters of phenylalanine | |
| CN1152865C (zh) | 赛利可喜的合成方法 | |
| NO141208B (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 2-(fenoksyalkyltio)imidazolforbindelser | |
| CH628014A5 (en) | Gamma-aryl-gamma-oxoisovaleric acids having antiphlogistic and antalgic properties | |
| US3905990A (en) | Basically substituted benzimidazole derivatives | |
| IE59151B1 (en) | New derivatives of 4-phenylpropyl indole and their salts, their preparation process, their use as medicaments and the pharmaceutical compositions containing them | |
| US4563477A (en) | Process for the preparation of alpha-(N-pyrrolyl)-derivative acids, the salts and esters thereof; alpha-(N-pyrrolyl)-phenylacetic acids, the esters thereof, pharmaceutical compositions containing them and therapeutical applications thereof | |
| EP0047207B1 (fr) | N-(1-allyl 2-pyrrolidinyl méthyl) 2-méthoxy 4-amino 5-méthylsulfamoyl benzamide, son procédé de préparation et son application comme médicament | |
| JPS5821624B2 (ja) | ３ カンジフエニルアミン − ユウドウタイノ セイホウ | |
| NZ200258A (en) | Indole derivatives and pharmaceutical compositions | |
| US4113877A (en) | Substituted 2-aminomethylphenyl sulfamates | |
| US4259257A (en) | 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives |